… options due to concerns with drug-development complexity, therapy accessibility and cost … , and commercial viability. RUR Drug Development Today Patient Access: RUR disease … -review vouchers to encourage RUR drug development. When a product for an …

However, with artificial intelligence (AI) now in use in nearly all fields of study, the drug discovery process has become more precise and efficient. In fact, around 80% of life and pharmaceutical sciences researchers have used this technology to support …

… for industry entitled “Disseminated Coccidioidomycosis: Developing Drugs for Treatment.” The purpose of …

… for industry entitled “Erosive Esophagitis: Developing Drugs for Treatment.” The draft guidance …

… “Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment.” The draft guidance …

Bio Hong Kong 2025 Artificial intelligence is no longer just a supporting tool in biotechnology – it is beginning to define the way drugs are discovered, tested and advanced into the clinic, speakers said during the Bio Hong Kong conference Sept. 10 to 13. …

… 2025-- The "Pharmaceutical Drug Development Annual Review - 2024… from the standpoint of drug development. It provides a high … Buy Insights on how drug development in 2024 may impact … 2024 may impact future drug development and approval trends Sales …

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering new FDA guidance on …